Ventyx Biosciences
Katie Shatara is an experienced professional in program management within the biotechnology and pharmaceutical sectors. Currently serving as Vice President and Head of Program Management at Ventyx Biosciences since September 2022, Katie has previously held significant roles at Gilead Sciences as Director of Project and Program Management, overseeing program strategy and global development for molecules in various clinical phases. Additional experience includes positions at Principia Biopharma, Dynavax Technologies, Genentech, Onyx Pharmaceuticals, and Amgen, where responsibilities encompassed project management, patient recruitment, and site operations. Katie holds a Bachelor's degree from the University of California, Berkeley, and completed training at the Co-Active Training Institute.
This person is not in any teams
This person is not in any offices
Ventyx Biosciences
1 followers
Ventyx Biosciences is a biotechnology company with a diverse portfolio of best-in-class highly differentiated clinical and pre-clinical stage programs focused on high-value targets. Ventyx now includes combined assets from three separate companies: Oppilan Pharma, targeting S1P1R, Zomagen Biosciences, targeting NLRP3 and the inflammasome, and Ventyx Biosciences, targeting TYK2.